Prenatal and early childhood phthalate exposures and thyroid function among school-age children

Kyoung-Nam Kim1, Hwa Young Kim2, Youn-Hee Lim3

  • 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Public Health and Preventive Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Insights

Early life exposure to phthalates, chemicals found in plastics, may impact children's thyroid function. This study linked prenatal and childhood phthalate levels to changes in thyroid hormones in school-aged children.

Area of Science:

  • Environmental Health
  • Endocrinology
  • Toxicology

Background:

  • Limited research exists on the connection between prenatal and early childhood phthalate exposure and thyroid function in children.
  • Phthalates are common endocrine-disrupting chemicals with potential health implications.

Purpose of the Study:

  • To examine the association between phthalate exposure during early life (prenatal and childhood) and thyroid function in school-aged children.
  • To utilize longitudinal data from a prospective cohort to understand these relationships over time.

Main Methods:

  • Urinary phthalate metabolite levels were measured during pregnancy and at ages 2, 4, and 6 years.
  • Thyroid function tests (TSH, T3, fT4) were conducted at age 6.
  • Associations were analyzed using linear regression and Bayesian kernel machine regression (BKMR) models in 492 children.

Main Results:

  • Higher prenatal mono-n-butyl phthalate (MnBP) and early childhood mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) exposures were linked to lower thyroid-stimulating hormone (TSH) levels.
  • Certain phthalate metabolites at ages 2 and 6 years were associated with elevated triiodothyronine (T3) levels.
  • Prenatal MnBP and early childhood MEHHP and MEOHP exposures were associated with lower free thyroxine (fT4) × TSH index.

Conclusions:

  • Early life phthalate exposure appears to influence thyroid function in school-aged children.
  • Findings suggest potential endocrine disruption effects of phthalates on the thyroid axis.
  • Results should be interpreted with caution due to the use of single spot urine samples for exposure assessment.
Abstract

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
126
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
646
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
167
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K